Example: Heart Attack

Search clinical trials for: Cardiac Glycosides

Total 177 results

NCT04327245

Completed

To Compare the Effects of Non-nutritive Sweeteners Intake in Woman With Insulin Resistance

Conditions: Insulin Resistance; Hyperinsulinism
NCT04287387

Not yet recruiting

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

Conditions: Type2 Diabetes Mellitus
NCT04215432

Completed

Propolis Extract, Nanovitamin C and Nanovitamin E in Peri-implant Mucositis

Conditions: Peri-implant Mucositis
NCT04180813

Recruiting

Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose

Conditions: Diabetes Mellitus, Type 2
NCT04138277

Recruiting

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With LOPD

Conditions: Pompe Disease (Late-onset)
NCT04135495

Recruiting

A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele

Conditions: Cystic Fibrosis
NCT04126473

Recruiting

A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele

Conditions: Genetic Disease; Nonsense Mutation; Cystic Fibrosis With Meconium Ileus
NCT04069260

Terminated

A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis

Conditions: Genetic Disease; Nonsense Mutation; Cystinosis
NCT04066803

Recruiting

Optimal MTX Dose With Folic Acid Randomized Case-control Trial

Conditions: Rheumatoid Arthritis
NCT04065581

Completed

Bioequivalence Study for Acarbose/Metformin FDC

Conditions: Diabetes Mellitus, Type 2
NCT03961659

Recruiting

Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.

Conditions: Type 2 Diabetes Mellitus; Obesity; Cognitive Impairment
NCT03928210

Not yet recruiting

Digoxin Induced Dissolution of CTC Clusters

Conditions: Breast Cancer; Circulating Tumor Cells (CTCs)
NCT03911505

Recruiting

ZIP Study - A Study to Evaluate the PK, Safety, Efficacy, and PD With ATB200/AT2221 in LOPD Subjects Aged 12 to <18

Conditions: Pompe Disease (Late-onset)
NCT03910621

Recruiting

Safety and Efficacy of Miglustat in Chinese NPC Patients

Conditions: Niemann-Pick Disease, Type C
NCT03822013

Recruiting

Effects of Miglustat Therapy on Infantile Type of Sandhoff and Taysachs Diseases (EMTISTD)

Conditions: GM2 Gangliosidosis; Supportive Care
NCT03794336

Recruiting

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Conditions: Type 2 Diabetes Mellitus
NCT03776539

Completed

A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02

Conditions: Impaired Renal Function
NCT03729362

Active, not recruiting

PROPEL Study - A Study Comparing ATB200/AT2221 With Alglucosidase/Placebo in Adult Subjects With LOPD

Conditions: Pompe Disease (Late-onset)
NCT03680482

Completed

To Compare the Effects of Non-nutritive Sweeteners Intake in Subjects With T2DM

Conditions: Diabetes Mellitus, Type 2
NCT03641482

Completed

NBF Gingival Gel Application After Impacted Lower Third Molar Surgery

Conditions: Alveolar Osteitis
NCT03608878

Recruiting

Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT Genotype

Conditions: Hepatocellular Carcinoma
NCT03608917

Unknown status

Efficacy and Safety of Total Glucosides of Paeony Combined With NB-UVB on Treating Vitiligo

Conditions: Vitiligo
NCT03602638

Not yet recruiting

Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

Conditions: Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
NCT03591471

Unknown status

Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment

Conditions: Henoch-Schönlein Purpura Nephritis
NCT03546283

Not yet recruiting

Neuroprotectant for Hypertensive Intracerebral Hemorrhage

Conditions: Intracerebral Hemorrhage
NCT03526081

Completed

Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides

Conditions: Healthy
NCT03383068

Unknown status

Research of Intensive Metabolic Intervention Before Pregnancy in PCOS

Conditions: PCOS; Impaired Glucose Tolerance
NCT03380546

Recruiting

Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.

Conditions: Gestational Diabetes Mellitus in Pregnancy
NCT03359837

Active, not recruiting

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy

Conditions: Type 2 Diabetes Mellitus
NCT03349684

Completed

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients

Conditions: Diabetes Mellitus, Type 2
NCT03344341

Terminated

A Phase IV Study in Drug-Naive Patients With T2DM in China

Conditions: Type 2 Diabetes Mellitus
NCT03309605

Completed

Phase 1 Study of ELX-02 in Healthy Adult Subjects

Conditions: Genetic Disease; Nonsense Mutation
NCT03259685

Recruiting

Effect of Non-nutritive Sweeteners of High Sugar Sweetened Beverages on Metabolic Health and Gut Microbiome

Conditions: Gut Microbiota; Metabolic Syndrome
NCT03241303

Completed

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

Conditions: Glucose Metabolism Disorders
NCT02999841

Unknown status

Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients

Conditions: Diabetes Mellitus, Type 2; Obesity
NCT02954692

Completed

A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

Conditions: Type 2 Diabetes Mellitus
NCT02953093

Active, not recruiting

Study of Acarbose in Longevity

Conditions: Aging
NCT02888470

Completed

Administration of Amino-glycoside in ICU Patients : Clinical Practices in 2013

Conditions: Sepsis
NCT02879955

Completed

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Conditions: Overweight
NCT02865499

Completed

Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)

Conditions: Aging
NCT02836704

Completed

Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)

Conditions: Diabetes Mellitus, Type 2
NCT02825823

Completed

The Effects of Exogenous Ketones on Exercise Performance in Young Healthy Adults

Conditions: Exercise; Ketones; Dietary Supplements
NCT02730377

Completed

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

Conditions: Diabetes; Diabetes Mellitus, Type 2
NCT02685852

Completed

Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

Conditions: Hyperinsulinemic Hypoglycemia
NCT02675465

Active, not recruiting

First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221

Conditions: Pompe Disease
NCT02605772

Unknown status

Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes

Conditions: Type 2 Diabetes Mellitus
NCT02589353

Recruiting

Human Oral Detection of Glucose Olygomers

Conditions: Healthy Volunteers
NCT02587741

Recruiting

Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens

Conditions: Diabetic Retinopathy
NCT02580110

Completed

On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota

Conditions: Healthy Subjects
NCT02527993

Completed

Treatment of Hypoglycemia Following Gastric Bypass Surgery

Conditions: Hypoglycemia; Obesity; Surgery